Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

11 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Virus inactivation by nucleic acid extraction reagents.
Blow JA, Dohm DJ, Negley DL, Mores CN. Blow JA, et al. Among authors: negley dl. J Virol Methods. 2004 Aug;119(2):195-8. doi: 10.1016/j.jviromet.2004.03.015. J Virol Methods. 2004. PMID: 15158603
Genomic differences between guinea pig lethal and nonlethal Marburg virus variants.
Lofts LL, Ibrahim MS, Negley DL, Hevey MC, Schmaljohn AL. Lofts LL, et al. Among authors: negley dl. J Infect Dis. 2007 Nov 15;196 Suppl 2:S305-12. doi: 10.1086/520585. J Infect Dis. 2007. PMID: 17940965
Marburg virus-like particles protect guinea pigs from lethal Marburg virus infection.
Warfield KL, Swenson DL, Negley DL, Schmaljohn AL, Aman MJ, Bavari S. Warfield KL, et al. Among authors: negley dl. Vaccine. 2004 Sep 3;22(25-26):3495-502. doi: 10.1016/j.vaccine.2004.01.063. Vaccine. 2004. PMID: 15308377
Marburg virus vaccines: comparing classical and new approaches.
Hevey M, Negley D, VanderZanden L, Tammariello RF, Geisbert J, Schmaljohn C, Smith JF, Jahrling PB, Schmaljohn AL. Hevey M, et al. Among authors: negley d. Vaccine. 2001 Nov 12;20(3-4):586-93. doi: 10.1016/s0264-410x(01)00353-x. Vaccine. 2001. PMID: 11672925
Induction of humoral and CD8+ T cell responses are required for protection against lethal Ebola virus infection.
Warfield KL, Olinger G, Deal EM, Swenson DL, Bailey M, Negley DL, Hart MK, Bavari S. Warfield KL, et al. Among authors: negley dl. J Immunol. 2005 Jul 15;175(2):1184-91. doi: 10.4049/jimmunol.175.2.1184. J Immunol. 2005. PMID: 16002721 Free article.
Antigenicity and vaccine potential of Marburg virus glycoprotein expressed by baculovirus recombinants.
Hevey M, Negley D, Geisbert J, Jahrling P, Schmaljohn A. Hevey M, et al. Among authors: negley d. Virology. 1997 Dec 8;239(1):206-16. doi: 10.1006/viro.1997.8883. Virology. 1997. PMID: 9426460
Characterization of monoclonal antibodies to Marburg virus (strain Musoke) glycoprotein and identification of two protective epitopes.
Hevey M, Negley D, Schmaljohn A. Hevey M, et al. Among authors: negley d. Virology. 2003 Sep 15;314(1):350-7. doi: 10.1016/s0042-6822(03)00416-1. Virology. 2003. PMID: 14517087
Isolation and initial characterization of a newfound hantavirus from California.
Schmaljohn AL, Li D, Negley DL, Bressler DS, Turell MJ, Korch GW, Ascher MS, Schmaljohn CS. Schmaljohn AL, et al. Among authors: negley dl. Virology. 1995 Feb 1;206(2):963-72. doi: 10.1006/viro.1995.1019. Virology. 1995. PMID: 7856107 Free article.
Virus-like particles exhibit potential as a pan-filovirus vaccine for both Ebola and Marburg viral infections.
Swenson DL, Warfield KL, Negley DL, Schmaljohn A, Aman MJ, Bavari S. Swenson DL, et al. Among authors: negley dl. Vaccine. 2005 Apr 27;23(23):3033-42. doi: 10.1016/j.vaccine.2004.11.070. Vaccine. 2005. PMID: 15811650
Ebola and Marburg viruses replicate in monocyte-derived dendritic cells without inducing the production of cytokines and full maturation.
Bosio CM, Aman MJ, Grogan C, Hogan R, Ruthel G, Negley D, Mohamadzadeh M, Bavari S, Schmaljohn A. Bosio CM, et al. Among authors: negley d. J Infect Dis. 2003 Dec 1;188(11):1630-8. doi: 10.1086/379199. Epub 2003 Nov 14. J Infect Dis. 2003. PMID: 14639532
11 results
Jump to page
Feedback